Ozempic and Wegovy are making so much money for Novo Nordisk A/S that their cumulative sales will soon surpass the drugmaker’s entire research budget for the past three decades, undercutting a key argument for their unusually high prices.

Lawmakers are set to scrutinize the high cost of weight loss and diabetes drugs, which depending upon your insurance can range from $0 a month to over $1,000 if it isn't covered.

Ozempic and Wegovy are making so much money for Novo Nordisk A/S that their cumulative sales will soon surpass the drugmaker’s entire research budget for the past three decades, undercutting a key argument for their unusually high prices.

Developed to treat diabetes, drugs like Ozempic now help fight obesity. Scientists newly honoured for working on them recall their findings Half a century of advances in biomedical science paved the way for today's powerful weight-loss drugs like Ozempic - so what was that journey like for the scientists involved?